01 January 2005
Experiences with three different fi ber supplements in weight reduction
Grethe Støa Birketvedt, Mona Shimshi, Erling Thom, Jon FlorholmenMed Sci Monit 2005; 11(1): PI5-8 :: ID: 13883
Abstract
Background: Fiber supplements added to a caloric diet have additional effects on weight reduction in overweight subjects. The aim of this study was to compare the effect of various commercial fiber supplements (glucomannan, guar gum and alginate) on weight reduction in healthy overweight subjects. Material/Methods: One hundred and seventy six men and women were included to receive either active fi ber substance or placebo in randomized placebo-controlled studies. The fi ber supplements consisted of the viscous fi bers glucomannan (Chrombalance[sup]®[/sup]), glucomannan and guar gum (Appe-Trim[sup]®[/sup]) and glucomannan, guar gum and alginat (Glucosahl).Results: All fi ber supplements plus a balanced 1200 kcal diet induced signifi cantly weight reduction more than placebo and diet alone, during a fi ve week observation period. However, there were no signifi cant differences between the different fi bers in their ability to induce weight reduction, which was approximately 0.8 kg/week (3.8±0.9, 4.4±2.0, 4.1±0.6 in the Chrombalance, Appe-Trim[sup]®[/sup] and Glucosahl group, respectively).Conclusions: Glucomannan induced body weight reduction in healthy overweight subjects, whereas the addition of guar gum and alginate did not seem to cause additional loss of weight.
Keywords: Alginates - therapeutic use, Dietary Fiber - therapeutic use, Galactans - therapeutic use, Glucuronic Acid - therapeutic use, Hexuronic Acids - therapeutic use, Mannans - therapeutic use, Weight Loss - drug effects, Alginates - therapeutic use, Dietary Fiber - therapeutic use, Galactans - therapeutic use, Glucuronic Acid - therapeutic use, Hexuronic Acids - therapeutic use, Mannans - therapeutic use, Obesity - diet therapy, Plant Gums, Weight Loss - drug effects
Editorial
01 July 2026 : Editorial
Editorial: The WHO Identifies Ebola Disease Due to Bundibugyo Virus as a Public Health Emergency of International Concern (PHEIC) as Vaccine Development AcceleratesDOI: 10.12659/MSM.954627
Med Sci Monit 2026; 32:e954627
In Press
Clinical Research
Effects of Single-Bout Endurance Exercise Intensity on Peripheral Neurotrophic Factors in Patients With Isc...Med Sci Monit In Press; DOI: 10.12659/MSM.952089
Review article
Anisodus tanguticus in Cancer Research: A Review of Traditional Use, Phytochemistry, Extraction Methods, an...Med Sci Monit In Press; DOI: 10.12659/MSM.952999
Clinical Research
Nasal Mucociliary Clearance and Its Relationship With Disease Severity in Patients With Multiple SclerosisMed Sci Monit In Press; DOI: 10.12659/MSM.952850
Clinical Research
Modified Thoracoabdominal Nerves Block Through the Perichondrial Approach vs Subcostal Transversus Abdomini...Med Sci Monit In Press; DOI: 10.12659/MSM.953976
Most Viewed Current Articles
17 Jan 2024 : Review article 14,176,570
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,762,188
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,466,310
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 708,927
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






